Cell and Gene Therapy Orchestration Solutions

This IDC Perspective frames CGT's "batch size of one" reality and positions orchestration as the workflow integration/control layer needed to scale autologous patient-product-patient operations. It spotlights the critical challenges, ensuring a secure COI/COC across a multi-enterprise network, constraint-heavy scheduling, interoperability across MES/LIMS/QMS/ERP and partner systems, and GxP-ready governance/auditability. It identifies specific use cases where AI can add value, along with the challenges. It provides practical buyer guidance and KPIs for CGT orchestration solutions."The future of precision medicine runs on CGT orchestration solutions: smart execution layers that connect manufacturing, QC, and cryologistics. They digitize COI/COC across the patient-product life cycle, compress vein-to-vein timelines, and optimize clinical outcomes," said Dr. Nimita Limaye, research vice president, Life Sciences R&D Strategy and Technology, IDC.